Cardiomyopathy, Dilated
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
512
|
509
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Alcohol Use Disorder
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
218
|
54
|
0.300 |
None |
1.000 |
1 |
|
1996 |
1996 |
Lymphatic Metastasis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
463
|
10
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Cardiomyopathy, Familial Idiopathic
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
773
|
243
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Estradiol measurement
|
phenotype |
|
Laboratory Procedure
|
21
|
75
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Testosterone measurement
|
phenotype |
|
Laboratory Procedure
|
14
|
23
|
0.100 |
None |
1.000 |
1 |
3
|
2011 |
2011 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Sex hormone binding globulin measurement
|
phenotype |
|
Laboratory Procedure
|
11
|
21
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Estradiol level result
|
phenotype |
|
Laboratory or Test Result
|
21
|
75
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
756
|
103
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Muscle Weakness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
536
|
87
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Malignant neoplasm of testis
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
253
|
31
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Clubbing
|
phenotype |
|
Sign or Symptom
|
32
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Depressive Symptoms
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
421
|
120
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Disorder of endocrine ovary
|
group |
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
22
|
1
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Malignant neoplasm of gallbladder
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
425
|
81
|
0.010 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Endometriosis of ovary
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
70
|
3
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Adult Liver Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1377
|
72
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cystadenocarcinoma, Serous
|
disease |
Neoplasms
|
Neoplastic Process
|
110
|
1
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Cystadenocarcinoma, Mucinous
|
disease |
Neoplasms
|
Neoplastic Process
|
13
|
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |